Concepedia

Kelsie Mozzoni

KM

4

Publications

610

Citations

4

H-Index

2014

Active since

Affiliations

Cognition Therapeutics (United States)(Current)

University of Kentucky

Columbia University

Kelsie Mozzoni is an author at Cognition Therapeutics (United States) specializing in cognitive function, synaptic signaling, and synaptic plasticity.

Top concepts

Publications per year

2014–2020

4

Publications

4

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Nicholas J. Izzo, Jinbin Xu, Chenbo Zeng et al. · PLoS ONE · 2014 · 292 citations · Full text

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Nicholas J. Izzo, Agnes Staniszewski, Lillian K. To et al. · PLoS ONE · 2014 · 185 citations · Full text

, , +18

A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease

Michael Grundman, Roger Morgan, Jason D. Lickliter et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 106 citations · Full text

Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

Colleen S. Limegrover, Harry LeVine, Nicholas J. Izzo et al. · Journal of Neurochemistry · 2020 · 27 citations · Full text

Rows per page

1–4 of 4